Home › Chronic Progressive Multiple Sclerosis › Ohio
Chronic Progressive Multiple Sclerosis clinical trials in Ohio
7 studies for Chronic Progressive Multiple Sclerosis are looking for participants at sites in Ohio.
Cities in Ohio
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- The Ohio State University Wexner Medical Center (OSUWMC), Columbus
- The Boster Center for Multiple Sclerosis, Columbus
RecruitingPhase 3
Ages 18 to 60 · All sexes · Updated Nov 12, 2026 · NCT07299019A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- The Ohio State University Wexner Medical Center (OSUWMC), Columbus
- The Boster Center for Multiple Sclerosis, Columbus
RecruitingPhase 3
Ages 18 to 60 · All sexes · Updated Nov 10, 2026 · NCT07067463A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
- Local Institution - Site 104, Columbus
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Oct 30, 2026 · NCT07840326Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- University of Cincinnati (UC) Waddell Center for Multiple Sclerosis, Cincinnati
- Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland
RecruitingPhase 3
Ages 18 to 55 · All sexes · Updated Oct 20, 2026 · NCT04047628A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Cleveland Clinic Ohio, Cleveland
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Oct 13, 2026 · NCT07225504Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- University of Cincinnati, Cincinnati
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Sep 21, 2026 · NCT07477639Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
- Cleveland State University, Cleveland
Recruiting
Ages 22 to 75 · All sexes · Updated Sep 24, 2025 · NCT05964829From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.